Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,445 | -3,520 | -1,571 | -18,676 | -10,874 |
| Depreciation Amortization | 199 | 49 | 294 | 133 | 74 |
| Accounts receivable | 1,887 | N/A | -1,556 | N/A | N/A |
| Accounts payable and accrued liabilities | -1,149 | -40 | 2,536 | 95 | 81 |
| Other Working Capital | -1,526 | -2,012 | -2,134 | 1,366 | 943 |
| Other Operating Activity | -697 | 559 | -430 | 1,864 | 1,233 |
| Operating Cash Flow | $-3,731 | $-4,964 | $-2,861 | $-15,218 | $-8,543 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 7,335 | N/A | 2,961 | 6,997 |
| PPE Investments | -16 | -1 | -688 | -32 | -25 |
| Investing Cash Flow | $-16 | $7,334 | $-688 | $2,929 | $6,972 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,489 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 6 | 6 |
| Financing Cash Flow | $5,489 | $N/A | $N/A | $6 | $6 |
| Beginning Cash Position | 8,345 | 2,304 | 11,894 | 16,658 | 16,658 |
| End Cash Position | 10,087 | 4,674 | 8,345 | 4,375 | 15,093 |
| Net Cash Flow | $1,742 | $2,370 | $-3,549 | $-12,283 | $-1,565 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,731 | -4,964 | -2,861 | -15,218 | -8,543 |
| Capital Expenditure | -16 | -1 | -688 | -32 | -25 |
| Free Cash Flow | -3,747 | -4,965 | -3,549 | -15,250 | -8,568 |